These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7090750)

  • 41. Correlation of midtrimester amniotic fluid cytokine concentrations with adverse pregnancy outcome in terms of spontaneous abortion, preterm birth, and preeclampsia.
    Bamberg C; Fotopoulou C; Thiem D; Roehr CC; Dudenhausen JW; Kalache KD
    J Matern Fetal Neonatal Med; 2012 Jun; 25(6):812-7. PubMed ID: 21726173
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Conservative management of second-trimester post-amniocentesis fluid leakage.
    Gold RB; Goyert GL; Schwartz DB; Evans MI; Seabolt LA
    Obstet Gynecol; 1989 Nov; 74(5):745-7. PubMed ID: 2812651
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Origin of amniocentesis-induced rises of alpha-fetoprotein concentrations in maternal serum.
    Dallaire L; Bélanger L; Smith CJ; Kelleher PC
    Br J Obstet Gynaecol; 1980 Oct; 87(10):856-9. PubMed ID: 6158990
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risks of midtrimester amniocentesis; assessment in 3000 pregnancies.
    Leschot NJ; Verjaal M; Treffers PE
    Br J Obstet Gynaecol; 1985 Aug; 92(8):804-7. PubMed ID: 4027202
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pregnancy loss rates after midtrimester amniocentesis.
    Eddleman KA; Malone FD; Sullivan L; Dukes K; Berkowitz RL; Kharbutli Y; Porter TF; Luthy DA; Comstock CH; Saade GR; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; D'Alton ME
    Obstet Gynecol; 2006 Nov; 108(5):1067-72. PubMed ID: 17077226
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Second-trimester echogenic bowel and intraamniotic bleeding: association between fetal bowel echogenicity and amniotic fluid spectrophotometry at 410 nm.
    Sepulveda W; Reid R; Nicolaidis P; Prendiville O; Chapman RS; Fisk NM
    Am J Obstet Gynecol; 1996 Mar; 174(3):839-42. PubMed ID: 8633653
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Frequency and importance of fetomaternal hemorrhages through early amniocentesis].
    Sender A; Pinon F; Maigret P; Henrion R; Chavinie J; Van Nifterik J
    Rev Fr Transfus Immunohematol; 1975 Dec; 18(4):373-84. PubMed ID: 819979
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Obstetrician-gynecologists performing genetic amniocentesis may be misleading themselves and their patients.
    Blessed WB; Lacoste H; Welch RA
    Am J Obstet Gynecol; 2001 Jun; 184(7):1340-2; discussion 1342-4. PubMed ID: 11408850
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Significant of meconium stained fluid in midtrimester amniocentesis.
    Immken L; Lee M; Stewart R; Kaback MM
    Birth Defects Orig Artic Ser; 1982; 18(3 Pt A):187-90. PubMed ID: 7126792
    [No Abstract]   [Full Text] [Related]  

  • 50. Fetal-maternal bleeding associated with genetic amniocentesis.
    Mennuti MT; Brummond W; Crombleholme WR; Schwarz RH; Arvan DA
    Obstet Gynecol; 1980 Jan; 55(1):48-54. PubMed ID: 6153239
    [TBL] [Abstract][Full Text] [Related]  

  • 51. On the complication risk of early amniocentesis versus standard amniocentesis.
    Eiben B; Hammans W; Hansen S; Trawicki W; Osthelder B; Stelzer A; Jaspers KD; Goebel R
    Fetal Diagn Ther; 1997; 12(3):140-4. PubMed ID: 9313070
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Elevated fetal fibronectin in midtrimester amniotic fluid is involved with the onset of preeclampsia.
    Sakura M; Nakabayashi M; Takeda Y; Sato K
    J Obstet Gynaecol Res; 1998 Feb; 24(1):73-6. PubMed ID: 9564109
    [TBL] [Abstract][Full Text] [Related]  

  • 53. One thousand consecutive midtrimester amniocenteses.
    Bartsch FK; Lundberg J; Wahlström J
    Obstet Gynecol; 1980 Mar; 55(3):305-8. PubMed ID: 7360427
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of complications in second trimester amniocentesis performed with 20G, 21G and 22G needles.
    Uludag S; Aydin Y; Ibrahimova F; Madazli R; Sen C
    J Perinat Med; 2010 Nov; 38(6):597-600. PubMed ID: 20707629
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Elevated amniotic fluid C-reactive protein at the time of genetic amniocentesis is a marker for preterm delivery.
    Ghezzi F; Franchi M; Raio L; Di Naro E; Bossi G; D'Eril GV; Bolis P
    Am J Obstet Gynecol; 2002 Feb; 186(2):268-73. PubMed ID: 11854648
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Routine assessment of amniotic fluid alpha-Fetoprotein in early second-trimester amniocentesis is no longer justified.
    Widlund KF; Gottvall T
    Acta Obstet Gynecol Scand; 2007; 86(2):167-71. PubMed ID: 17364279
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of ultrasonography on midtrimester genetic amniocentesis complications.
    Nolan GH; Schmickel RD; Chantaratherakitti P; Knickerbocker C; Hamman J; Louwsma G
    Am J Obstet Gynecol; 1981 Jul; 140(5):531-4. PubMed ID: 7246688
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fetal loss rate after second trimester amniocentesis at different gestational age.
    Saltvedt S; Almström H
    Acta Obstet Gynecol Scand; 1999 Jan; 78(1):10-4. PubMed ID: 9926885
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Five-year experience with midtrimester amniocentesis performed by a single group of obstetricians-gynecologists at a community hospital.
    Blackwell SC; Abundis MG; Nehra PC
    Am J Obstet Gynecol; 2002 Jun; 186(6):1130-2. PubMed ID: 12066085
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Spontaneous abortion after midtrimester amniocentesis.
    Park IJ; Heller RH; Kaiser RM; Jones HW
    Obstet Gynecol; 1979 Feb; 53(2):190-4. PubMed ID: 418974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.